Condensed Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows used in operating activities
Net income (loss)	$ (131,000)	$ 313,000
Adjustments to reconcile net loss to net cash used in operating activities
Gain on sale of assets	0	(450,000)
Depreciation, depletion, amortization and valuation provision	6,000	9,000
Decrease (increase) in accounts receivable	(3,000)	2,000
Decrease (increase) in other assets	4,000	(5,000)
Increase in accounts payable	0	2,000
Increase in other accrued expenses	67,000	0
Operating lease	(1,000)
Net cash used in operating activities	(58,000)	(129,000)
Cash flows from investing activities
Proceeds from sale of assets	0	450,000
Net cash provided by investing activities	0	450,000
Cash flows from financing activities
Acquisition of treasury stock	(68,000)	0
Net cash used in financing activities	(68,000)	0
Net increase (decrease) in cash and cash equivalents	(126,000)	321,000
Cash and cash equivalents at beginning of year	2,358,000	2,037,000
Cash and cash equivalents at end of year	$ 2,232,000	$ 2,358,000